CD8A and hepatocellular carcinoma: Despite all these important insights into TAA-specific CD8+ T-cell immunity, their low frequency and thus the requirement for in vitro expansion for proper T-cell analysis has hampered the analysis of the ex vivo molecular properties of TAA-specific CD8+ T cells in HCC.